The Swiss drug maker Roche announced yesterday that it has obtained approval from the US Food and Drug Administration to use the company's Alexis IL-6 test to help early detection of patients with the most severe respiratory syndrome (Coronavirus) who will need Putting them on artificial respirators, which helps reduce the chances of their health deteriorating.
"Roche" indicated that the test can help doctors, in addition to a set of tests and other vital factors, in deciding whether a newborn coronavirus patient will need an artificial respirator or not at an early stage of his infection.
This test measures the level of the presence of the substance "Inter Lukin 6" (IL-6) in the blood, which is considered an early indication of the willingness to develop acute inflammation, which helps in early intervention to help patients with critical conditions.
Hospitals and reference laboratories can test "Alexis IL-6" using Roche's electronic Cubas analyzers, located in most countries of the world. These automated devices can show the results of the analysis within 18 minutes, whereby a single device can perform up to 300 analyzes per hour.
The United States recorded, on Wednesday evening, less than a thousand deaths from the emerging corona virus during the past 24 hours, bringing the total deaths from the epidemic in this country to more than 107 thousand deaths, according to a toll prepared by Johns Hopkins University.
Data published by the university, which is a reference in tracking infections and deaths caused by the emerging corona virus, showed that the number of those who died from Covid-19 in the United States within 24 hours reached 919, thus exceeding the total number of epidemic victims in this country, 107 thousand Person.
The total number of people infected with the virus in the United States exceeded one million and 850 thousand infected.
And the United States is, and is vastly different from the rest of the world, the country most affected by "Covid-19" in terms of injuries and deaths.